Recent development of technology and application of photoacoustic molecular imaging toward clinical translation

Jaesok Yu, Ho Nhu Y. Nguyen, Wiendelt Steenbergen (Corresponding Author), Kang Kim

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
29 Downloads (Pure)

Abstract

The deep imaging capability and optical absorption contrast offered by photoacoustic imaging promote the use of this technology in clinical applications. By exploiting the optical absorption properties of endogenous chromophores such as hemoglobin and lipid, molecular information at a depth of a few centimeters can be unveiled. This information shows promise to reveal lesions indicating early stage of various human diseases, such as cancer and atherosclerosis. In addition, the use of exogenous contrast agents can further extend the capability of photoacoustic imaging in clinical diagnosis and treatment. In this review, the current state of the art and applications of photoacoustic molecular probes will be critically reviewed, as well as some spearheading translational efforts that have taken place over the past 5 years. Some of the most critical barriers to clinical translation of this novel technology will be discussed, and some thoughts will be given on future endeavors and pathways.

Original languageEnglish
Pages (from-to)1202-1207
Number of pages6
JournalJournal of nuclear medicine
Volume59
Issue number8
DOIs
Publication statusPublished - 1 Aug 2018

Fingerprint

Photoacoustic Techniques
Molecular Imaging
Technology
Molecular Probes
Optical Imaging
Contrast Media
Atherosclerosis
Hemoglobins
Lipids
Neoplasms

Keywords

  • Contrast agents
  • Endogenous
  • Exogenous
  • Molecular imaging
  • Photoacoustic

Cite this

@article{a5aa7dad6e794c48abfeb1f08711fc07,
title = "Recent development of technology and application of photoacoustic molecular imaging toward clinical translation",
abstract = "The deep imaging capability and optical absorption contrast offered by photoacoustic imaging promote the use of this technology in clinical applications. By exploiting the optical absorption properties of endogenous chromophores such as hemoglobin and lipid, molecular information at a depth of a few centimeters can be unveiled. This information shows promise to reveal lesions indicating early stage of various human diseases, such as cancer and atherosclerosis. In addition, the use of exogenous contrast agents can further extend the capability of photoacoustic imaging in clinical diagnosis and treatment. In this review, the current state of the art and applications of photoacoustic molecular probes will be critically reviewed, as well as some spearheading translational efforts that have taken place over the past 5 years. Some of the most critical barriers to clinical translation of this novel technology will be discussed, and some thoughts will be given on future endeavors and pathways.",
keywords = "Contrast agents, Endogenous, Exogenous, Molecular imaging, Photoacoustic",
author = "Jaesok Yu and Nguyen, {Ho Nhu Y.} and Wiendelt Steenbergen and Kang Kim",
year = "2018",
month = "8",
day = "1",
doi = "10.2967/jnumed.117.201459",
language = "English",
volume = "59",
pages = "1202--1207",
journal = "Journal of nuclear medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "8",

}

Recent development of technology and application of photoacoustic molecular imaging toward clinical translation. / Yu, Jaesok; Nguyen, Ho Nhu Y.; Steenbergen, Wiendelt (Corresponding Author); Kim, Kang.

In: Journal of nuclear medicine, Vol. 59, No. 8, 01.08.2018, p. 1202-1207.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Recent development of technology and application of photoacoustic molecular imaging toward clinical translation

AU - Yu, Jaesok

AU - Nguyen, Ho Nhu Y.

AU - Steenbergen, Wiendelt

AU - Kim, Kang

PY - 2018/8/1

Y1 - 2018/8/1

N2 - The deep imaging capability and optical absorption contrast offered by photoacoustic imaging promote the use of this technology in clinical applications. By exploiting the optical absorption properties of endogenous chromophores such as hemoglobin and lipid, molecular information at a depth of a few centimeters can be unveiled. This information shows promise to reveal lesions indicating early stage of various human diseases, such as cancer and atherosclerosis. In addition, the use of exogenous contrast agents can further extend the capability of photoacoustic imaging in clinical diagnosis and treatment. In this review, the current state of the art and applications of photoacoustic molecular probes will be critically reviewed, as well as some spearheading translational efforts that have taken place over the past 5 years. Some of the most critical barriers to clinical translation of this novel technology will be discussed, and some thoughts will be given on future endeavors and pathways.

AB - The deep imaging capability and optical absorption contrast offered by photoacoustic imaging promote the use of this technology in clinical applications. By exploiting the optical absorption properties of endogenous chromophores such as hemoglobin and lipid, molecular information at a depth of a few centimeters can be unveiled. This information shows promise to reveal lesions indicating early stage of various human diseases, such as cancer and atherosclerosis. In addition, the use of exogenous contrast agents can further extend the capability of photoacoustic imaging in clinical diagnosis and treatment. In this review, the current state of the art and applications of photoacoustic molecular probes will be critically reviewed, as well as some spearheading translational efforts that have taken place over the past 5 years. Some of the most critical barriers to clinical translation of this novel technology will be discussed, and some thoughts will be given on future endeavors and pathways.

KW - Contrast agents

KW - Endogenous

KW - Exogenous

KW - Molecular imaging

KW - Photoacoustic

UR - http://www.scopus.com/inward/record.url?scp=85051252687&partnerID=8YFLogxK

U2 - 10.2967/jnumed.117.201459

DO - 10.2967/jnumed.117.201459

M3 - Article

VL - 59

SP - 1202

EP - 1207

JO - Journal of nuclear medicine

JF - Journal of nuclear medicine

SN - 0161-5505

IS - 8

ER -